Hyperforin, the main antidepressant constituent of Hypericum
perforatum, influences the extracellular concentrations of transmitters in
vitro and in
vivo. In
vivo experiments have shown that hyperforin enhances the extracellular concentrations
of dopamine, norepinephrine, serotonin and glutamate in the locus coeruleus. Hyperforin-free
Hypericum extract also elevates the extracellular concentrations of dopamine and norepinephrine
in the locus coeruleus, but, in contrast to hyperforin, the extracellular concentration
of serotonin is diminished. The differing profiles of hyperforin and hyperforin-free
Hypericum extract on the extracellular transmitter concentrations point to the presence of
an additional biologically active compound in Hypericum
perforatum. Inescapable shock increases the release of monoamines and several amino acids, as
well as motility, blood pressure and heart rate. Conditioned fear, similar to hyperforin-free
Hypericum extract, decreases the release of serotonin in the locus coeruleus. Conditioned fear
also leads to tachycardia. The latter finding shows that telemetric heart rate recording
is a good index for conditioned fear. In
vivo findings confirm the idea that the anti-depressive properties of Hypericum extract and hyperforin result from increases in extracellular neurotransmitter concentrations.
Since hyperforin-free extract, like conditioned fear, reduces the extracellular concentration
of serotonin, hyperforin may be more beneficial than Hypericum extract in the treatment of depressive disorders.
References
- 1
Benveniste H.
Brain microdialysis.
J Neurochem .
1989;
52
1667-1679
- 2
Bremmer J D, JH Krystal SM Southwick D S.
Charney: Noradrenergic mechanisms in stress and anxiety.
Synapse.
1996;
23
28-38
- 3
Chatterjee S S, Bhattacharya S K, Wonnemann M, Singer A, Müller W E.
Hyperforin as a possible antidepressant component of hypericum extracts.
Life Sci.
1998;
63
499-510
- 4
Di Chiara G, Tanda G, Carboni E.
Estimation of in vivo neurotransmitter release by brain microdialysis: the issue of
validity.
Behav Pharmacol.
1996;
7
640-657
- 5 Finlay J M, Zigmond M J.
A critical analysis of neurochemical methods for monitoring transmitter dynamics in
the brain. In: BloomE, DJ Kupfer (eds) The fourth generation of progress. New York; Raven Press
1995: pp. 29-40
- 6
Graef F G, Viana M B, Mora P O.
Opposed regulation by dorsal raphe nucleus 5-HT pathway of two types of fear in the
elevated T-maze.
Pharmacol Biochem Behav.
1996;
53
171-177
- 7
Handley S L, McBlane W.
Serotonin mechanisms in animal models of anxiety.
Braz J Med Biol Res.
1993;
26
1-13
- 8
Harro J, Oreland L.
Depression as a spreading neuronal adjustment disorder.
Eur Neuropharmacol.
1996;
6
207-223
- 9 Kaehler S T, Sinne C r, Chatterjee S S, Philippu A. Effects of hyperforin-free hypericum
extract on transmitter release in the rat locus coeruleus (submitted).
- 10
Kaehler S T, Sinner C, Chatterjee S S, Philippu A.
Hyperforin enhances the extracellular concentrations of catecholamines, serotonin
and glutamate in the rat locus coeruleus.
Neurosci Lett.
1999a;
262
199-202
- 11
Kaehler S T, Singewald N, Philippu A.
The release of catecholamines in hypothalamus and locus coeruleus is modulated by
peripheral chemoreceptors.
Naunyn-Schmiedeberg's Arch Pharmacol.
1999b;
360
428-434
- 12
Kaehler S T, Sinner C, Kouvelas D, Philippu A.
Effects of inescapable shock and conditioned fear on the release of excitatory and
inhibitory amino acids in the locus coeruleus.
Naunyn-Schmiedeberg's Arch Pharmacol.
2000a;
361
193-199
- 13
Kaehler S T, Singewald N, Sinner C, Thurnher C, Philippu A.
Conditioned fear and inescapable shock modify the release of serotonin in the locus
coeruleus.
Brain Res.
2000b;
859
249-254
- 14 Maier S F.
Learned helplessness: relationships with fear and anxiety. In: StanfordC, P Salmon (eds) Stress: From synapse to syndrome. Orlando; Academic
Press 1993: pp. 207-248
- 15
Müller W E, Rolli M, Schäfer C, Hafner U.
Effects of hypericum extract (LI 160) in biochemical models of antidepressant actvity.
Pharmaco- psychiatry.
1997;
30
((Suppl. 2))
102-107
- 16 Müller W E, Chatterjee S S. Hyperforin and the antidepressant activity of St. John's
Wort. Pharmacophychiatry 1998: 1-60
- 17
Myers R D, Adell A, Lankford M F.
Simultaneous comparison of cerebral dialysis and push-pull perfusion in the brain
of rats: a critical review.
Neurosci Biobiobehav Rev.
1998;
22
371-387
- 18
Perovic S, Müller W EG.
Pharmacological profile of hypericum extract.
Arzneim Forsch/Drug Res.
1995;
45
1145-1148
- 19 Philippu A.
Use of push-pull cannulae to determine the release of endogenous neurotransmitters
in distinct brain areas of anaesthetized and freely moving animals. In: Marsden CA (ed.) Measurement of neurotransmitter release in vivo. Chichester;
John Wiley 1984: pp. 3-37
- 20
Philippu A.
Analysis of hypothalamic transmitter release during cardiocascular cardiovascular
changes.
Ann NY Acad Sci.
1985a;
472
140-150
- 21 Philippu A.
The use of push-pull cannulae for superfusing various hypothalamic areas in anaesthetized
and conscious, freely moving animals. In: Bayon A, R Drucker-Colin (eds.) In vivo perfusion and release of neuroactive
substances. Methods and strategies. Orlando; Academic Press 1985b: pp. 221-232
- 22
Philippu A.
Regulation of blood pressure by central neurotransmitters and neuropeptides.
Rev Biochem Pharmacol.
1988;
111
1-115
- 23
Philippu A, Prast H, Singewald N.
Identification and dynamics of neuronal modulation and function in brain structures
and nuclei by continuous determination of transmitter release rates using the push-pull
superfusion technique: a compelling approach to in vivo brain research.
Sci Pharm.
1996;
64
609-618
- 24
Przuntek H, Philippu A.
Reduced pressor responses to stimulation of the locus coeruleus after lesion of the
posterior hypothalamus.
Naunyn-Schmiedeberg's Arch Pharmacol.
1993;
276
119-122
- 25
Rolli M, Schäfer C, Müller W E.
Effect of hypericum extract (LI 160) on neurotransmitter receptor binding and synaptosomal
uptake systems.
Pharmacopsychiatry.
1995;
28
207
- 26
Schneider C, Singewald N, Philippu A.
Inhibition of catecholamine (norepinephrine, dopamine) release in the locus coeruleus
and the hypothalamus by baroreceptor activation: identification of the involved baroreceptors.
Naunyn-Schmiedeberg¿s Arch Pharmacol.
1995;
352
291-296
- 27
Singewald N, Guo L J, Schneider C, Kaehler S, Philippu A.
Serotonin outflow in the hypothalamus of conscious rats: origin and possible involvement
in cardiovascular control.
Eur J Pharnacol.
1995;
294
787-793
- 28
Singewald N, Philippu A.
Catecholamine release in the locus coeruleus is modified by experimentally induced
changes in haemodynamics.
Naunyn-Schmiedeberg¿s Arch Pharmacol.
1993;
347
356-363
- 29
Singewald N, Philippu A.
Involvement of biogenic amines in the central regulation of cardiovascular homeostasis.
Trends Pharmacol Sci.
1996;
17
356-363
- 30
Singewald N, Kaehler S, Hemeida R, Philippu A.
Release of serotonin in the rat locus coeruleus: Effect(s) of cardiovascular, stressful
and noxious stimuli.
Eur J Neurosci.
1997a;
9
556-562
- 31
Singewald N, Kouvelas D, Chen F, Philippu A.
The release of inhibitory amino acids in the hypothalamus is tonically modified by
impulses from aortic baroreceptors as a consequence of blood pressure fluctuations.
Naunyn-Schmiedeberg¿s Arch Pharmacol.
1997b;
356
348-355
- 32
Singewald N, Philippu A.
Release of neurotransmitters in the locus coeruleus.
Progr Neurobiol.
1998;
56
237-267
- 33 Singewald N, Kouvelas D, Kaehler S T, Sinner C, Philippu A. Peripheral chemoreceptor
activation enhances 5-HT release in the locus coeruleus of conscious rats. Neurosc
Lett 2000:
- 34 Stricker-Krongrad A, Beck B, Burlet C. Microdialysis and push-pull Supefusion to
estimate hypothalamic paraventricular neurpeptide Y release. 6th International conference
on in vivo Methods 1994: 354-355
- 35
Timmerman W, Westerink B HC.
Brain microdialysis of GABA and glutamate: what does it signify?.
Synapse.
1997;
27
242-261
Athineos Philippu
Department of Pharmacology and Toxicology
University of Innsbruck
Peter-Mayr-Strasse 1
6020 Innsbruck
Austria